KODIAK SCIENCES INC. Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
KODIAK SCIENCES INC. (KOD) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent · last filed 2026-03-31
- KODIAK SCIENCES INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2024-12-31 was $0.00.
- KODIAK SCIENCES INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2024-09-30 was $0.00.
- KODIAK SCIENCES INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2024-06-30 was $0.00, a 100.00% decline year-over-year.
- KODIAK SCIENCES INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2024-03-31 was $0.00, a 100.00% decline year-over-year.
- KODIAK SCIENCES INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2025 was $0.00.
- KODIAK SCIENCES INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- KODIAK SCIENCES INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2023 was $1.31M.
- KODIAK SCIENCES INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2022 was -$1.31M.
| Period end | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-31 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $0.00 derived: sum of 2 quarters · filed 2026-03-31 | $0.00 derived: sum of 3 quarters · filed 2026-03-31 | $0.00 10-K · filed 2026-03-31 |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-14 | $0.00 derived: sum of 2 quarters · filed 2024-11-14 | $0.00 10-Q · filed 2024-11-14 | $0.00 derived: sum of 4 quarters · filed 2026-03-31 |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-14 | $0.00 10-Q · filed 2024-08-14 | $0.00 derived: sum of 3 quarters · filed 2026-03-31 | $0.00 derived: sum of 4 quarters · filed 2026-03-31 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-15 | $0.00 derived: sum of 2 quarters · filed 2026-03-31 | $0.00 derived: sum of 3 quarters · filed 2026-03-31 | $96.00K derived: sum of 4 quarters · filed 2026-03-31 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $0.00 derived: sum of 2 quarters · filed 2026-03-31 | $96.00K derived: sum of 3 quarters · filed 2026-03-31 | $1.31M 10-K · filed 2026-03-31 |
| 2023-09-30 | $0.00 10-Q · filed 2024-11-14 | $96.00K derived: sum of 2 quarters · filed 2024-11-14 | $1.31M 10-Q · filed 2024-11-14 | $2.50M derived: sum of 4 quarters · filed 2025-03-27 |
| 2023-06-30 | $96.00K 10-Q · filed 2024-11-14 | $1.31M 10-Q · filed 2024-08-14 | $2.50M derived: sum of 3 quarters · filed 2025-03-27 | $1.87M derived: sum of 4 quarters · filed 2025-03-27 |
| 2023-03-31 | $1.21M 10-Q · filed 2024-11-14 | $2.41M derived: sum of 2 quarters · filed 2025-03-27 | $1.77M derived: sum of 3 quarters · filed 2025-03-27 | -$96.00K derived: sum of 4 quarters · filed 2025-03-27 |
| 2022-12-31 | $1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $562.00K derived: sum of 2 quarters · filed 2025-03-27 | -$1.31M derived: sum of 3 quarters · filed 2025-03-27 | -$1.31M 10-K · filed 2025-03-27 |
| 2022-09-30 | -$636.00K 10-Q · filed 2023-11-14 | -$2.50M derived: sum of 2 quarters · filed 2023-11-14 | -$2.50M 10-Q · filed 2023-11-14 | -$2.50M derived: sum of 4 quarters · filed 2024-03-28 |
| 2022-06-30 | -$1.87M 10-Q · filed 2023-11-14 | -$1.87M 10-Q · filed 2023-08-14 | -$1.87M derived: sum of 3 quarters · filed 2024-03-28 | -$1.87M derived: sum of 4 quarters · filed 2024-03-28 |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-15 | $0.00 derived: sum of 2 quarters · filed 2024-03-28 | $0.00 derived: sum of 3 quarters · filed 2024-03-28 | -$18.00K derived: sum of 4 quarters · filed 2024-03-28 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $0.00 derived: sum of 2 quarters · filed 2024-03-28 | -$18.00K derived: sum of 3 quarters · filed 2024-03-28 | -$53.00K 10-K · filed 2024-03-28 |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-09 | -$18.00K derived: sum of 2 quarters · filed 2022-11-09 | -$53.00K 10-Q · filed 2022-11-09 | -$245.00K derived: sum of 4 quarters · filed 2023-03-28 |
| 2021-06-30 | -$18.00K 10-Q · filed 2022-11-09 | -$53.00K 10-Q · filed 2022-08-09 | -$245.00K derived: sum of 3 quarters · filed 2023-03-28 | -$594.00K derived: sum of 4 quarters · filed 2023-03-28 |
| 2021-03-31 | -$35.00K 10-Q · filed 2022-11-09 | -$227.00K derived: sum of 2 quarters · filed 2023-03-28 | -$576.00K derived: sum of 3 quarters · filed 2023-03-28 | -$471.00K derived: sum of 4 quarters · filed 2023-03-28 |
| 2020-12-31 | -$192.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | -$541.00K derived: sum of 2 quarters · filed 2023-03-28 | -$436.00K derived: sum of 3 quarters · filed 2023-03-28 | $43.00K 10-K · filed 2023-03-28 |
| 2020-09-30 | -$349.00K 10-Q · filed 2021-11-09 | -$244.00K derived: sum of 2 quarters · filed 2021-11-09 | $235.00K 10-Q · filed 2021-11-09 | $226.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $105.00K 10-Q · filed 2021-11-09 | $584.00K 10-Q · filed 2021-08-09 | $575.00K derived: sum of 3 quarters · filed 2022-03-01 | $582.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $479.00K 10-Q · filed 2021-11-09 | $470.00K derived: sum of 2 quarters · filed 2022-03-01 | $477.00K derived: sum of 3 quarters · filed 2022-03-01 | $483.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | -$9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$2.00K derived: sum of 2 quarters · filed 2022-03-01 | $4.00K derived: sum of 3 quarters · filed 2022-03-01 | $10.00K 10-K · filed 2022-03-01 |
| 2019-09-30 | $7.00K 10-Q · filed 2020-11-09 | $13.00K derived: sum of 2 quarters · filed 2020-11-09 | $19.00K 10-Q · filed 2020-11-09 | |
| 2019-06-30 | $6.00K 10-Q · filed 2020-11-09 | $12.00K 10-Q · filed 2020-08-10 | ||
| 2019-03-31 | $6.00K 10-Q · filed 2020-11-09 | |||
| 2018-09-30 | $0.00 10-Q · filed 2019-11-12 | $0.00 derived: sum of 2 quarters · filed 2019-11-12 | $0.00 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $0.00 10-Q · filed 2019-08-14 | $0.00 10-Q · filed 2019-08-14 | ||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |